Publicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (32)

2024

  1. Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort

    Sleep Medicine, Vol. 116, pp. 19-26

  2. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology, Vol. 15

2023

  1. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project

    Nutrients, Vol. 15, Núm. 1

  2. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

    Atherosclerosis, Vol. 380

2021

  1. Clinical usefulness of anthropometric indices to predict the presence of prediabetes. Data from the Ilervas cohort

    Nutrients, Vol. 13, Núm. 3, pp. 1-15

2020

  1. Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 1, pp. 130-138

  2. Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 34, Núm. 12, pp. 2079-2088

  2. Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  3. Lung function measurements in the prediabetes stage: data from the ILERVAS Project

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012

  4. Sex hormones and their influence on chronic kidney disease

    Current Opinion in Nephrology and Hypertension, Vol. 28, Núm. 1, pp. 1-9

  5. Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project

    Diabetes and Metabolism

2018

  1. Peritoneal dialysis is an independent factor associated to lower intima media thickness in dialysis patients free from previous cardiovascular disease

    Frontiers in Physiology, Vol. 9

2017

  1. Effects of the administration of 25(OH) vitamin D3 in an experimental model of chronic kidney disease in animals null for 1-alpha-hydroxylase

    PLoS ONE, Vol. 12, Núm. 1

  2. Low Serum Levels of Vitamin D are Associated with Progression of Subclinical Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients: A Prospective, Multicenter Study

    Nephron, Vol. 136, Núm. 2, pp. 111-120

  3. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease

    Atherosclerosis, Vol. 260, pp. 130-137

  4. The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease

    PLoS ONE, Vol. 12, Núm. 11

2016

  1. Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease

    Atherosclerosis, Vol. 253, pp. 135-143

  2. Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD

    Clinical Journal of the American Society of Nephrology, Vol. 11, Núm. 2, pp. 287-296

  3. Soluble TWEAK and major adverse cardiovascular events in patients with CKD

    Clinical Journal of the American Society of Nephrology, Vol. 11, Núm. 3, pp. 413-422